- •Type 1diabetes mellitus
- •Type 1diabetes mellitus
- •Diabetes mellitus
- •Diabetes insipidus
- •Type 1diabetes mellitus, inadequate control, ketosis
- •Correlates with determination of potential abnormalities of glucose tolerance
- •Impairment of carbohydrate tolerance
- •Remission of diabetes mellitus
- •Diabetes Insipidus
- •Type 2 diabetes mellitus
- •Type 1diabetes mellitus
- •Definition of the c-peptide level
- •Type 2 diabetes mellitus, diabetic angiopathy, foot ulcers
- •Diabetes insipidus
- •Type 2 diabetes mellitus, inadequate control
- •Type 2 diabetes mellitus, inadequate control, ketoacidosis
- •Type 2 Diabetes mellitus, hard form in the stage of compensation. Chronic pyelonephritis, high pressure disease
- •Type 2 Diabetes Mellitus, inadequate control, diabetic nephropathy, microalbuminuria
- •Oral glucose tolerance test (gtt) and fasting serum lipid studies
- •Determination level of the HbAlc
- •All of the above
- •All of the above
- •Options a and b
- •An a1c can be drawn quarterly in patients whose therapy has just changed or who are not meeting glycemic control. In patients who are at glycemic control, it can be drawn twice a year
- •Tight blood pressure control that includes an angiotensin-converting enzyme inhibitor
- •Type 1diabetes mellitus, diabetic background retinopathy, diabetic foot syndrome
- •Type 1 diabetes mellitus, diabetic distal symmetrical sensorimotor polyneuropathy
- •Type 1 diabetes mellitus in the stage of decompensation
- •Diabetic gastroenteropathy
- •Diabetic nephropathy
- •Diabetes insipidus
- •Ketoacidotic coma
- •Ketoacidotic coma
- •Diabetic ketoacidotic coma
- •Rapid-acting insulin in the dose of 10 u hourly I/V
- •Diabetic ketoacidosis
- •Lactic acidosis
- •Somogyi effect
- •0, 5 Iu/kg/daily
- •Diet with carbohydrate restriction
- •Diet recommendations
- •Transfer to monotherapy by short acting insulin
- •Rapid-acting insulin in the dose of 10 u hourly I/V
- •Can be done, but is not recommended by most physicians
- •Gdm is typically found in the third trimester
- •All of the above
- •Proliferative retinopathy
- •Good and protracted compensation of diabetes mellitus
- •Diet with carbohydrate restriction
- •Diet recommendations
- •Reduction in triglycerides
- •Agree with the mother that her suspicions are probably true
- •Ketoacidotic coma
- •Diffuse toxic goiter
- •Thyrotoxic crisis
- •Endemic diffuse nontoxic goiter of 3 grade
- •Graves’ disease
- •Diffuse toxic goiter
- •Thyrotoxic crisis
- •Thiamazole
- •Nodular goiter 3 grade, thyrothoxicosis
- •Diffuse toxic goiter in decompensation. Thyrotoxic crisis.
- •Nodular goiter
- •Autoimmune (Hashimotos) thyroiditis, hypothyroidism
- •All methods
- •Subacute thyroiditis
- •Syndrome of Van – Vik – Ross – Geness
- •Myxedema coma
- •Nodular euthyreoid goiter
- •Aspirational biopsy
- •Antibiotics
- •Salicylates and corticosteroids
- •Surgery
- •Primary hypoparathyroidism
- •Postoperative hypoparathyroidism
- •Primary hyperparathyroidism
- •Hypoparathyroidism
- •Post-operative hypoparathyroidism
- •Primary hyperparathyroidism
- •Primary hyperparathyroidism, renal form
- •Pseudohypoparathyroidism
- •Primary hyperparathyroidism
- •Primary hyperparathyroidism
- •Hypotension
- •Addison’s disease
- •Intestinal colic
- •In the diagnostic approach to determine hypercortisolism
- •Cushing’s syndrome. Steroid’s diabetes
- •All of the above
- •Conn’s syndrome
- •Phaeochromocytoma
- •All of the above
- •Acute adrenal insufficiency
- •Cushing’s syndrome
- •Salt-wasting congenital adrenal hyperplasia (cah) from mineralocorticoid deficiency
- •Measure plasma vasopressin before and after an infusion of hypertonic saline
- •Patau syndrome
- •Down's syndrome
- •Follicle Stimulating Hormone (fsh)
- •Diabetes mellitus
- •Steroid diabetes
- •Hypothyrosis
- •Diabetes mellitus
- •Diabetes insipidus
- •Diabetes insipidus
- •Pituitary tumor
- •Obesity class III
- •Pubertal-juvenile dispituitarism
- •Alimentary obesity
- •Hypothalamic obesity
- •Adipose-genital dystrophy
- •Arterial hypertension
- •Hypothalamic obesity
- •Hypothalamic obesity, class II
- •Cushing disease, obesity, class II
- •Hypothalamic obesity, class II
- •Alimentary constitutive obesity, class II
- •Shereshevsky-Turner syndrome
- •Secondary sexual characters development
- •Increasing of the thyroxin and triiodothyronine level
- •Diabetes mellitus
- •Melatonin
- •Adrenal gland
- •1,5 Mmol/l
- •Alkaptonuria
- •Down's syndrome
Turner's syndrome
Patau syndrome
Morris's syndrome
Klinefelter's syndrome
Down's syndrome
Case 115. A 24 years old man is refferred because incidentally discovered pituitary adenoma. He relates that he was involved in an automobile accident three weeks earlier. Magnetic resonance imaging performed to evaluate the consequences of head trauma revealed a 7 mm area in the right side of the pituitary that did not emit as bright a signal following gadolinium as did the rest of the pituitary. On questioning, he said he had been felling generally well. Specifically, he had experienced headaches for a week after the accident but not before or since. He had not noted a change in libido, potency, or appearance. Objective status: height -160 cm; weight -75,5 kg, blood pressure was 118/82 mmHg; pulse - 72 beats/min and regular. He didn’t appear acromegalic or to have Cushing’s syndrome. He had no lid lag or lid retraction. His thyroid gland was not palpably enlarged. Serum rolactin concentration was 12 ng/mL (normal<15 ng/mL). Which one of the following tests should you order next?
Thyroid Stimulating Hormone (TSH)
Visual fields
Luteinizing Hormone (LH)
Follicle Stimulating Hormone (fsh)
Insulin-like growth factor-1 (IGF – 1)
Case 116. Patient F., 57 years old, complains of general weakness, headache, weight gain, menstrual irregularity, hirsutism, frequent urination and thirst. Objective status: height - 157 cm, weight - 92 kg. Localization of fat tissue is disproportional, being found mostly on the face, neck and trunk with relatively thin extremities. Face is ruddy, “moon face”. There are dark red striae under her arms, on the inner surfaces of the hips and on the belly. Skin is normal, moist, pulse - 70 beats/min, blood pressure – 180/100 mmHg. Over her upper lip and chin large amount of hair growth (patient shaves). Laboratory tests: 17-OHCS is elevated, oral glucose tolerance test (OGTT) – 6.2-10.8-9.4 mmol/l, glucose in urine – 0.5%. What is the most likely diagnosis?
Diabetes mellitus
Arterial hypertension
Itsenko-Cushing syndrome, steroid diabetes
Obesity
Steroid diabetes
Case 117. A 45 year old man was referred by his dentist for prognathism and malocclusion. Shoe size had increased from 6 to 8 in the last six years and the patient complained of excessive sweating, headache, but denied change in sexual activity. Objective status: the patient had a prominent jaw, spacing of the teeth, thick skin and the thyroid was enlarged 2 times normal size, and felt firm and finely nodular. The rest of the examination was normal except for large, spade-like hands and feet. Laboratory evaluation revealed: fasting growth hormone increase 1,5 times normal, fasting glucose was 6,5 mmol/L. The most likely diagnosis is:
Gigantism
Obesity
Acromegaly
Physiologic Growth Hormone variation
Hypothyrosis
Case 118. Patient S., 33 years old, complains of a tiresome thirst (drinks 8-12 l/day), mouth dryness, frequent urination, weight loss and headache. In the anamnesis - tree months ago patient suffered a craniocerebral injury. Objective status: height – 174 cm, weight – 53 kg, skin is dry, turgor decreased. Blood pressure – 110/60 mmHg, pulse –70 beats/min. Result of laboratory tests: specific gravity 1002-1004, oral glucose tolerance test – 4.7-7.1-5.5 mmol/l. X-ray of the cranium – normal, eye fields – normal. What diagnosis would you suggest?
